Medical devices, healthcare technology and the business of care
510(k) clearance · K261125

BodyTom 64 (NL4100); OmniTom Elite (NL5000)

Samsung HME America, Inc., dba NeuroLogica Corp. · Decision date Sep 22, 2026

MEDTECHLEDGER EXPLANATIONK261125

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision on September 22, 2026 for K261125, a traditional 510(k) submitted by Samsung HME America, Inc., dba NeuroLogica Corp. of Danvers, Massachusetts, covering the BodyTom 64 (NL4100) and OmniTom Elite (NL5000) computed tomography x-ray systems under 21 CFR 892.1750, Class II, product code JAK, in the radiology specialty. The submission was received April 6, 2026, and the review was not performed by a third party.

The cleared change is software only: the Samsung Weighted Filtered Back Projection (S-FBP) reconstruction algorithm, identical for both systems, with no hardware changes. The summary names BodyTom 64 (K242811) as predicate and OmniTom Elite (K233767) as reference device, and states the indications for use are unchanged and identical to those of the predicates. The summary reports a statistically significant reduction in image noise with S-FBP; independent clinical performance data are not in the provided record.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Sep 22, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261125
Regulatory pathway
510(k) premarket notification
Product code
JAK
Decision code
SESE
Decision date
Sep 22, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: System, X-Ray, Tomography, Computed.

Product code
JAK
FDA device class
2

FDA decision timeline

  1. K261125 received

    Application receipt date recorded by FDA.

  2. K261125 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code JAK

Product / regulatory recordCompanyPathwayDecision dateSource
Coreline Soft Co., Ltd.510(k) clearanceOct 16, 2026FDA
CAS-One IRK261225
Cascination AG510(k) clearanceSep 29, 2026FDA
Fujifilm Corporation510(k) clearanceSep 18, 2026FDA
Fujifilm Corporation510(k) clearanceSep 4, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Samsung HME America, Inc., dba NeuroLogica Corp.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Danvers, MA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records